- About bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Millions will die if India stops AIDS drugs — UN
- A sex worker holds a placard during an AIDS awareness rally to mark the World AIDS Day in Siliguri December 1, 2008. REUTERS/Rupak De Chowdhuri/Files
Millions will die if India stops AIDS drugs — U.N.
By Nita Bhalla
NEW DELHI | Tue Jul 5, 2011
(Reuters) — Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.
The EU and India are currently negotiating a free-trade agreement, which campaigners say will restrict India’s ability to produce anti-retroviral (ARV) drugs, preventing the world’s poor from accessing cheap drugs for their treatment.
"India should resist removing any flexibility because any trade agreement which could lead to India not being able to produce will be terrible for the rest of the world," said Michel Sidibe, executive director for the Joint United Nations Programme on HIV/AIDS (UNAIDS).
"Millions of people will die if India cannot produce and Africa will be the most affected. For me, it is an issue of life or death," he told Reuters in an interview, adding that about 86 percent of people on treatment were taking drugs made in India.
The EU-India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms, requiring data exclusivity and tightening border enforcement rules.
Such moves could drive up prices for India’s anti-retroviral treatments, limit dosage options and delay access to newer and better drugs, said a U.N. report in September last year.
REVERSING GAINS MADE
Thirty years after the HIV/AIDS virus was first discovered, experts say while substantial progress has been made by the global community in stemming it, only a fraction of those living with the illness are on medication.
At a high level U.N. meeting last month, nations agreed on a set of ambitious targets to rid the world of disease, including scaling up the provision of generics to reach 15 million patients from six million by 2015.
The trade deal, Sidibe said, would reverse many of the gains made in improving the lives of the world’s poor.
"We have been fighting for so long to make sure that poor people could have access to treatment," he said. "For me, it will be the beginning of reversing all the gains we made on social justice and redistribution of opportunity."
Sidibe, a Mali national, said African leaders were asking India to really pay serious attention to any trade agreement which would block them to produce quality generic drugs for very poor people.
"It is not a rich pocket of people in the developed world who will be deprived of drugs, it will be the most needy, the most poor."
(Editing by Yoko Nishikawa)
News from the movements
11-Feb-2016 Biodiversidad en América LatinaDefender la primacía de los derechos humanos sobre las ganancias de las corporaciones es decir NO al TPP.
An assessment of the possible implications of the EAC-EU EPA on Kenyan agricultural sector and its compatibility with the WTO rulesThe full implementation of EPA, may shift consumption away from local products, to EU goods.
9-Feb-2016 EDRiThe greatest concerns regarding TiSA involve the introduction of greater limitations on the government’s right to regulate and the inclusion of potentially harmful provisions for the protection of the fundamental rights to privacy and data protection.
8-Feb-2016 ITUCThe ITUC has called the Trans-Pacific Partnership Agreement (TPP) a major setback for employment and workers’ rights prospects, and signaled the determination of unions in TPP countries to oppose it.
5-Feb-2016 MSFMSF urges all ASEAN member states to lead an effort to reject the ratification and implementation of the TPP and the expansion of its negative consequences for public health in the whole region.
5-Feb-2016 ISCKim-Hwang Kyeongsan, General Secretary of the Korean Woman Peasants’ Association, explains the government’s recent rice policy that hurts rice farmers and impacts Korea’s food sovereignty and how FTAs make it worse.
1-Feb-2016 War on WantGerman MPs will be granted restricted access to documents from secret EU-US trade negotiations. Access to the documents will only be possible under supervision.
1-Feb-2016 AFL-CIOThe U.S. government claims the labor protections in the Trans-Pacific Partnership are “gold standard,” but we need to look no further than Honduras to see how inadequate and unenforced labor obligations endanger workers’ lives.
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Get involved.